Illuminant Surgical, a medical technology company developing advanced surgical visualization systems, announced an $8.4 million seed round featured in Fortune, to accelerate engineering, manufacturing, and clinical development.
The funding has enabled the launch of a new 12,000 sq ft headquarters in Los Angeles, bringing R&D labs, pilot manufacturing, and a BSL-2 cadaver lab into one integrated facility, reducing time from clinical insight to product delivery.
Product Development and Launch
The company is preparing to roll out its first production-equivalent Skylight systems from its in-house manufacturing line in the coming weeks, marking a key step toward commercialization.
Mission and Vision
Illuminant Surgical aims to enhance surgical precision and outcomes through advanced technology designed to support clinical decision-making.
“Our mission is simple: we want doctors to never miss.”